Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insmed (INSM) Cash from Financing Activities (2016 - 2026)

Insmed's Cash from Financing Activities history spans 17 years, with the latest figure at $29.5 million for Q1 2026.

  • Quarterly Cash from Financing Activities rose 1.78% to $29.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $954.6 million through Mar 2026, down 30.17% year-over-year, with the annual reading at $954.1 million for FY2025, 28.85% down from the prior year.
  • Cash from Financing Activities came in at $29.5 million for Q1 2026, down from $33.9 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $857.8 million in Q2 2025 to a low of -$399000.0 in Q1 2023.
  • The 5-year median for Cash from Financing Activities is $33.9 million (2025), against an average of $193.3 million.
  • Year-over-year, Cash from Financing Activities crashed 106.18% in 2023 and then skyrocketed 31701.44% in 2024.
  • Insmed's Cash from Financing Activities stood at $743.4 million in 2022, then crashed by 83.42% to $123.3 million in 2023, then rose by 29.24% to $159.3 million in 2024, then tumbled by 78.75% to $33.9 million in 2025, then decreased by 12.83% to $29.5 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Cash from Financing Activities are $29.5 million (Q1 2026), $33.9 million (Q4 2025), and $33.4 million (Q3 2025).